rabeprazole krka 10mg gastro-resistant tablets
krka, d.d., novo mesto - rabeprazole sodium - gastro-resistant tablet - 10 milligram(s) - proton pump inhibitors; rabeprazole
rabeprazole krka 20mg gastro-resistant tablets
krka, d.d., novo mesto - rabeprazole sodium - gastro-resistant tablet - 20 milligram(s) - proton pump inhibitors; rabeprazole
ramipril krka 2.5 mg tablets
krka, d.d., novo mesto - ramipril - tablet - 2.5 milligram(s) - ace inhibitors, plain; ramipril
ramipril krka 1.25 mg tablets
krka, d.d., novo mesto - ramipril - tablet - 1.25 milligram(s) - ace inhibitors, plain; ramipril
ramipril krka 5 mg tablets
krka, d.d., novo mesto - ramipril - tablet - 5 milligram(s) - ace inhibitors, plain; ramipril
ramipril krka 10 mg tablets
krka, d.d., novo mesto - ramipril - tablet - 10 milligram(s) - ace inhibitors, plain; ramipril
lansoprazole krka 15 mg gastro-resistant capsules, hard
krka, d.d., novo mesto - lansoprazole - gastro-resistant capsule, hard - 15 milligram(s) - proton pump inhibitors; lansoprazole - proton pump inhibitors - treatment of duodenal and gastric ulcer treatment of reflux oesophagitis prophylaxis of reflux oesophagitis eradication of helicobacter pylori (h. pylori) concurrently given with appropriate antibiotic therapy for treatment of h. pylori-associated ulcers treatmat of nsaid-associated benign gastric and duodenal ulcers in patients requiring continued nsaidtreatment prophylaxis of nsaid-associated gastric ulcers and duodenal ulcers in patients at risk (see section 4.2) requiring continued therapy symptomatic gastro-oesophageal reflux disease zollinger-ellison syndrome
lansoprazole krka 30 mg gastro-resistant capsules, hard
krka, d.d., novo mesto - lansoprazole - gastro-resistant capsule, hard - 30 milligram(s) - proton pump inhibitors; lansoprazole - : proton pump inhibitors - treatment of duodenal and gastric ulcer treatment of reflux oesophagitis prophylaxis of reflux oesophagitis eradication of helicobacter pylori (h. pylori) concurrently given with appropriate antibiotic therapy for treatment of h. pylori-associated ulcers treatmat of nsaid-associated benign gastric and duodenal ulcers in patients requiring continued nsaidtreatment prophylaxis of nsaid-associated gastric ulcers and duodenal ulcers in patients at risk (see section 4.2) requiring continued therapy symptomatic gastro-oesophageal reflux disease zollinger-ellison syndrome
rosuvastatin/amlodipine krka 10mg/5mg film-coated tablets
krka d.d., novo mesto - rosuvastatin; amlodipine - film-coated tablet - 10 mg/5 milligram(s) - hmg coa reductase inhibitors, other combinations; zzz rosuvastatin and amlodipine
rosuvastatin/amlodipine krka 10mg/10mg film-coated tablets
krka d.d., novo mesto - rosuvastatin; amlodipine - film-coated tablet - 10 mg/10 milligram(s) - hmg coa reductase inhibitors, other combinations; zzz rosuvastatin and amlodipine